A detailed history of Vanguard Group Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Vanguard Group Inc holds 6,448,689 shares of JAZZ stock, worth $697 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,448,689
Previous 6,363,748 1.33%
Holding current value
$697 Million
Previous $783 Million 0.79%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$115.19 - $132.77 $9.78 Million - $11.3 Million
84,941 Added 1.33%
6,448,689 $777 Million
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $1.75 Million - $2.08 Million
-15,305 Reduced 0.24%
6,363,748 $783 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $3.66 Million - $4.35 Million
29,960 Added 0.47%
6,379,053 $826 Million
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $21.3 Million - $25.6 Million
174,029 Added 2.82%
6,349,093 $787 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $16.7 Million - $20 Million
124,439 Added 2.06%
6,175,064 $904 Million
Q4 2022

Feb 10, 2023

BUY
$129.72 - $159.85 $21 Million - $25.9 Million
161,859 Added 2.75%
6,050,625 $964 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $16.7 Million - $21.2 Million
131,570 Added 2.29%
5,888,766 $785 Million
Q2 2022

Aug 12, 2022

BUY
$141.59 - $168.66 $21.9 Million - $26.1 Million
154,546 Added 2.76%
5,757,196 $898 Million
Q1 2022

May 13, 2022

BUY
$129.64 - $160.7 $7.51 Million - $9.31 Million
57,949 Added 1.05%
5,602,650 $872 Million
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $7.97 Million - $9.69 Million
66,529 Added 1.21%
5,544,701 $706 Million
Q3 2021

Nov 12, 2021

SELL
$128.64 - $184.79 $682,692 - $980,680
-5,307 Reduced 0.1%
5,478,172 $713 Million
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $878 Million - $1.02 Billion
5,483,479 New
5,483,479 $974 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.77B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.